NOTES PAYABLE – RELATED PARTIES (Details Narrative) - USD ($) |
3 Months Ended | 5 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 05, 2026 |
Aug. 15, 2023 |
Mar. 31, 2026 |
Dec. 31, 2025 |
Jan. 02, 2026 |
Aug. 27, 2025 |
Jan. 23, 2025 |
Oct. 23, 2024 |
Sep. 25, 2024 |
Jul. 31, 2022 |
Jul. 31, 2021 |
|
| Promissory Note [Member] | |||||||||||
| Short-Term Debt [Line Items] | |||||||||||
| Promissory notes, principal amount | $ 100,000 | $ 25,000 | |||||||||
| Accrued interest rate | 11.00% | ||||||||||
| Maturity date | Jun. 30, 2026 | ||||||||||
| Frost Gamma Investments Trust [Member] | |||||||||||
| Short-Term Debt [Line Items] | |||||||||||
| Notes payable, description | The Company has outstanding notes payable to Frost Gamma Investments Trust (“Frost Gamma”) which pertained to promissory notes issued in fiscal 2021 and 2022, in the principal amount of $75,000 and $75,000, respectively. The promissory notes accrue interest at a rate of 11% per annum, payable on the maturity date on June 30, 2026, as amended on January 5, 2026. The Frost Gamma promissory note may be prepaid in advance of the maturity date without penalty. Frost Gamma is a trust controlled by Dr. Phillip Frost, a current director of the Company, and who beneficially owns in excess of 10% of the Company’s common stock. | ||||||||||
| Outstanding notes payable balance | $ 570,000 | $ 470,000 | |||||||||
| Frost Gamma Investments Trust [Member] | Promissory Note [Member] | |||||||||||
| Short-Term Debt [Line Items] | |||||||||||
| Notes payable, description | the Company entered into a new promissory note agreement with Frost Gamma in the principal amount of $200,000, which also accrues interest at a rate of 11% per annum, payable on the maturity date June 30, 2026, as amended on January 5, 2026. This promissory note may also be prepaid in advance of the maturity date without penalty. | ||||||||||
| Promissory notes, principal amount | $ 200,000 | $ 120,000 | $ 120,000 | $ 120,000 | $ 120,000 | $ 75,000 | $ 75,000 | ||||
| Accrued interest rate | 11.00% | ||||||||||
| Maturity date | Jun. 30, 2026 | ||||||||||
| Payments on promissory notes | 0 | ||||||||||
| Dr. Jane Hsiao [Member] | |||||||||||
| Short-Term Debt [Line Items] | |||||||||||
| Payments on promissory notes | 0 | 0 | |||||||||
| Outstanding notes payable balance | $ 150,000 | $ 150,000 | |||||||||
| Maturity date description | to extend the maturity date from December 31, 2025 to June 30, 2026 | ||||||||||
| Dr. Jane Hsiao [Member] | Promissory Note [Member] | |||||||||||
| Short-Term Debt [Line Items] | |||||||||||
| Notes payable, description | The Company has outstanding notes payable Jane Hsiao, Ph.D. (“Dr. Hsiao”) which pertained to promissory notes issued in fiscal 2021 and 2022, in the principal amount of $75,000 and $75,000, respectively. The promissory notes accrue interest at a rate of 11% per annum, payable on the maturity date on June 30, 2026, as amended on January 5, 2026. The promissory notes to Dr. Hsiao may be prepaid in advance of the maturity date without penalty. Dr. Hsiao is the Company’s Chairman and Interim CEO, and who beneficially owns in excess of 10% of the Company’s common stock. | ||||||||||
| Promissory notes, principal amount | $ 75,000 | $ 75,000 | |||||||||
| Accrued interest rate | 11.00% | ||||||||||
| Maturity date | Jun. 30, 2026 |